Xiaoling Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoling Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Fanding He
Department of Medical Ultrasound, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China
1 shared publicationJing Qiao
Department of Ultrasound, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China
1 shared publication- Qi Luo
Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
1 shared publication Weihan Xiao
North Sichuan Medical College, Nanchong 637000 China
1 shared publicationXia Han
Department of Obstetrics and Gynecology, Shenzhen Hospital of Guangzhou University of Chinese Medicine (Futian), Shenzhen, Guangdong, China
1 shared publication- Xiachuan Qin
Department of Ultrasound, West China School of Medicine, Sichuan University, Sichuan University affiliated Chengdu Second People’s Hospital, Chengdu Second People’s Hospital, Chengdu, China
1 shared publication
Latest Publications
- 3 September 2024
- Published by Elsevier in Academic Radiology
- Vol. 31 (11) , 4499-4508
Prediction of Lymph Node Metastasis in Endometrial Cancer Based on Color Doppler Ultrasound Radiomics
- 3 September 2024
- Published by Elsevier in Academic Radiology
- Vol. 31 (11) , 4499-4508
Prediction of Lymph Node Metastasis in Endometrial Cancer Based on Color Doppler Ultrasound Radiomics
- Open Access
- 23 December 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (51) , e27690
FANCI may serve as a prognostic biomarker for cervical cancer
Background: DNA damage is a fundamental process that plays a considerable role in generating protein diversity. FANCI, loaded on the altered chromatin, plays a vital role in DNA damage. Abnormal FANCI expression is potentially associated with carcinogenesis.However, the biological role of FANCI in cervical cancer is yet to be determined. Methods: We analyzed FANCI expression via multiple gene expression databases. Genes co-expressed with FANCI and its regulators were identified using LinkedOmics. The correlations between FANCI and cancer immune infiltrates were investigated via Tumor Immune Estimation Resource (TIMER). Results: FANCI was found upregulated with amplification in tumor tissues of multiple cervical cancer cohorts. High FANCI expression was associated with poorer overall survival (OS). Functional network analysis suggested that FANCI regulates spliceosome, DNA replication, and cell cycle signaling via pathways involving several cancer-related kinases and the E2F family. In additional, FANCI expression was positively correlated with infiltrating levels of CD4+ T and CD8+ T cells, and neutrophils. FANCI expression also showed strong correlations with diverse immune marker sets in cervical cancer. Conclusion: These findings suggested that FANCI is correlated with prognosis of and immune infiltration in cervical cancer, laying a foundation for further study of the immune regulatory role of FANCI in cervical cancer.
- 23 December 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (51) , e27690
Open AccessFANCI may serve as a prognostic biomarker for cervical cancer
Background: DNA damage is a fundamental process that plays a considerable role in generating protein diversity. FANCI, loaded on the altered chromatin, plays a vital role in DNA damage. Abnormal FANCI expression is potentially associated with carcinogenesis.However, the biological role of FANCI in cervical cancer is yet to be determined. Methods: We analyzed FANCI expression via multiple gene expression databases. Genes co-expressed with FANCI and its regulators were identified using LinkedOmics. The correlations between FANCI and cancer immune infiltrates were investigated via Tumor Immune Estimation Resource (TIMER). Results: FANCI was found upregulated with amplification in tumor tissues of multiple cervical cancer cohorts. High FANCI expression was associated with poorer overall survival (OS). Functional network analysis suggested that FANCI regulates spliceosome, DNA replication, and cell cycle signaling via pathways involving several cancer-related kinases and the E2F family. In additional, FANCI expression was positively correlated with infiltrating levels of CD4+ T and CD8+ T cells, and neutrophils. FANCI expression also showed strong correlations with diverse immune marker sets in cervical cancer. Conclusion: These findings suggested that FANCI is correlated with prognosis of and immune infiltration in cervical cancer, laying a foundation for further study of the immune regulatory role of FANCI in cervical cancer.